SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-045796
Filing Date
2021-08-26
Accepted
2021-08-25 21:36:22
Documents
86
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q emma-10q_20200331.htm   iXBRL 10-Q 3525922
2 EX-31.1 emma-ex311_8.htm EX-31.1 9934
3 EX-31.2 emma-ex312_7.htm EX-31.2 10012
4 EX-32.1 emma-ex321_6.htm EX-32.1 7812
  Complete submission text file 0001564590-21-045796.txt   19664488

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA emma-20200331.xsd EX-101.SCH 83270
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE emma-20200331_cal.xml EX-101.CAL 96689
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE emma-20200331_def.xml EX-101.DEF 397445
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE emma-20200331_lab.xml EX-101.LAB 614922
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE emma-20200331_pre.xml EX-101.PRE 582363
10 EXTRACTED XBRL INSTANCE DOCUMENT emma-10q_20200331_htm.xml XML 5841454
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 211208614
SIC: 2834 Pharmaceutical Preparations